Montse Roset

1.2k total citations
31 papers, 981 citations indexed

About

Montse Roset is a scholar working on Surgery, Gastroenterology and Rheumatology. According to data from OpenAlex, Montse Roset has authored 31 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Gastroenterology and 6 papers in Rheumatology. Recurrent topics in Montse Roset's work include Gastrointestinal motility and disorders (8 papers), Pelvic floor disorders treatments (3 papers) and Dermatology and Skin Diseases (3 papers). Montse Roset is often cited by papers focused on Gastrointestinal motility and disorders (8 papers), Pelvic floor disorders treatments (3 papers) and Dermatology and Skin Diseases (3 papers). Montse Roset collaborates with scholars based in Spain, United Kingdom and United States. Montse Roset's co-authors include Xavier Badı́a, Michael Herdman, Ángela María Segura Cardona, Fermín Mearin, Eva Baró, Mercedes Cucala, Natalia Zárate, Isabel Pérez‐Martínez, Julio Ponce and Manuel Díaz‐Rubio and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and BMJ Open.

In The Last Decade

Montse Roset

29 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Montse Roset Spain 13 311 266 182 136 120 31 981
Tamar Freud Israel 21 499 1.6× 563 2.1× 218 1.2× 97 0.7× 264 2.2× 84 1.8k
Steve Fullerton United States 6 464 1.5× 276 1.0× 127 0.7× 57 0.4× 69 0.6× 9 810
Jan-Samuel Wagner United States 14 202 0.6× 143 0.5× 74 0.4× 89 0.7× 146 1.2× 22 959
F.G. Schellevis Netherlands 13 137 0.4× 133 0.5× 151 0.8× 43 0.3× 143 1.2× 31 748
Petra Jellema Netherlands 23 201 0.6× 393 1.5× 91 0.5× 258 1.9× 195 1.6× 36 1.9k
Miren Orive Spain 12 53 0.2× 242 0.9× 68 0.4× 83 0.6× 89 0.7× 28 643
Corine Penning Netherlands 25 240 0.8× 447 1.7× 250 1.4× 549 4.0× 323 2.7× 58 1.8k
Paul Crosland Australia 13 102 0.3× 99 0.4× 96 0.5× 75 0.6× 40 0.3× 29 605
Joseph A. Crawley United States 16 1.2k 3.8× 979 3.7× 244 1.3× 57 0.4× 67 0.6× 35 1.6k
Judith D. Bentkover United States 14 83 0.3× 255 1.0× 53 0.3× 76 0.6× 628 5.2× 25 1.6k

Countries citing papers authored by Montse Roset

Since Specialization
Citations

This map shows the geographic impact of Montse Roset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montse Roset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montse Roset more than expected).

Fields of papers citing papers by Montse Roset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Montse Roset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montse Roset. The network helps show where Montse Roset may publish in the future.

Co-authorship network of co-authors of Montse Roset

This figure shows the co-authorship network connecting the top 25 collaborators of Montse Roset. A scholar is included among the top collaborators of Montse Roset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montse Roset. Montse Roset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durante‐Mangoni, Emanuele, Lorenzo Bertolino, Claudio Maria Mastroianni, et al.. (2021). Complicated carbapenem-resistant infections: a treatment pathway analysis in Italian sites. Infezioni in Medicina. 29(3). 434–449. 2 indexed citations
2.
Cañete, Juan D., et al.. (2019). Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento. Reumatología Clínica. 16(6). 447–454. 4 indexed citations
4.
Monteagudo, Mónica, Montse Roset, Teresa Rodríguez-Blanco, Laura Muñoz, & Marc Miravitlles. (2017). Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study. International Journal of COPD. Volume 12. 1145–1152. 12 indexed citations
5.
Roset, Montse, et al.. (2017). Impacto de los síntomas de vejiga hiperactiva sobre la actividad laboral: estudio ACTIVHA. Actas Urológicas Españolas. 42(3). 176–184. 7 indexed citations
6.
Rosell, Antoni, Núria Rodríguez, Eduard Monsó, et al.. (2016). Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patients. Lung Cancer. 94. 102–107. 1 indexed citations
8.
Roset, Montse, et al.. (2014). Health Care Cost Associated To Constipation Predominant Irritable Bowel Syndrome In Spain. Value in Health. 17(7). A365–A365. 1 indexed citations
9.
Roset, Montse, Xavier Badı́a, Anna Forsythe, & Susan M. Webb. (2013). Mapping CushingQoL Scores onto SF-6D Utility Values in Patients with Cushing’s Syndrome. Patient. 6(2). 103–111. 25 indexed citations
10.
Roset, Montse, Manuel Luque‐Ramírez, Susan M. Webb, et al.. (2012). Cost of Clinical Management of Acromegaly in Spain. Clinical Drug Investigation. 32(4). 235–245. 28 indexed citations
11.
Daudén, E., Enrique Herrera, L. Puig, et al.. (2012). Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Health and Quality of Life Outcomes. 10(1). 56–56. 22 indexed citations
12.
Ng‐Mak, Daisy, et al.. (2012). Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases. Cephalalgia. 32(12). 875–887. 17 indexed citations
13.
Daudén, E., J. Sánchez‐Pérez, María Dolores Prieto, & Montse Roset. (2011). Validación de la versión española de la escala de intensidad del picor (Cuestionario Itch Severity Scale, ISS). Estudio PSEDA. Actas Dermo-Sifiliográficas. 102(7). 527–536. 11 indexed citations
14.
Garrigues, Vicente, Fermín Mearin, Xavier Badı́a, et al.. (2007). Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1‐year follow‐up study (RITMO study). Alimentary Pharmacology & Therapeutics. 25(3). 323–332. 51 indexed citations
15.
Benavent, Jaume, et al.. (2006). Impact of upper digestive symptoms in patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology. 18(12). 1271–1277. 21 indexed citations
16.
Mearin, Fermín, Montse Roset, Xavier Badı́a, et al.. (2004). Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria. The American Journal of Gastroenterology. 99(1). 122–130. 37 indexed citations
17.
Mearin, Fermín, Eva Baró, Montse Roset, et al.. (2004). Clinical Patterns Over Time in Irritable Bowel Syndrome: Symptom Instability and Severity Variability. The American Journal of Gastroenterology. 99(1). 113–121. 92 indexed citations
18.
Mearin, Fermín, Agustín Balboa, Xavier Badı́a, et al.. (2003). Irritable bowel syndrome subtypes according to bowel habit. European Journal of Gastroenterology & Hepatology. 15(2). 165–172. 90 indexed citations
19.
Prieto, Luis, Montse Roset, & Xavier Badía. (2001). Rasch measurement in the Assessment of Growth Hormone Deficiency in adult patients.. PubMed. 2(1). 48–64. 8 indexed citations
20.
Badı́a, Xavier, et al.. (1999). [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale].. PubMed. 112 Suppl 1. 79–85. 461 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026